Clinical Trial

The Glaucoma and Retinopathy Screening Study

Study acronym: GRaSS
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-03-12; most recent amendment 2025-08-26.
Status change: Not Yet Recruiting → Recruiting 2025-06-28
Trial Details
NCT Number NCT06882356
Lead Sponsor Massachusetts Eye and Ear Infirmary
Collaborators: Centers for Disease Control and Prevention
Conditions Glaucoma
Enrollment 2,000 participants
Start Date 2025-07-16
Primary Completion 2030-09 (estimated)
Study Completion 2030-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-28